Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING

Open access
Luo, Xiaobo, Donnelly, Christopher R., Gong, Wang, Heath, Blake R., Hao, Yuning, Donnelly, Lorenza A., Moghbeli, Toktam, Tan, Yee Sun, Lin, Xin, Bellile, Emily, Kansy, Benjamin A., Carey, Thomas E., Brenner, J. Chad, Cheng, Lei, Polverini, Peter J., Morgan, Meredith A., Wen, Haitao, Prince, Mark E., Ferris, Robert L., Xie, Yuying, Young, Simon, Wolf, Gregory T., Chen, Qianming, Lei, Yu L. · 2020 · Journal of Clinical Investigation

Abstract

The incidence of human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma (HNSCC) has surpassed that of cervical cancer and is projected to increase rapidly until 2060. The coevolution of HPV with transforming epithelial cells leads to the shutdown of host immune detection. Targeting proximal viral nucleic acid-sensing machinery is an evolutionarily conserved strategy among viruses to enable immune evasion. However, E7 from the dominant HPV subtype 16 in HNSCC shares low homology with HPV18 E7, which was shown to inhibit the STING DNA-sensing pathway. The mechanisms by which HPV16 suppresses STING remain unknown. Recently, we characterized the role of the STING/type I interferon (IFN-I) pathway in maintaining immunogenicity of HNSCC in mouse models. Here we extended those findings into the clinical domain using tissue microarrays and machine learning-enhanced profiling of STING signatures with immune subsets. We additionally showed that HPV16 E7 uses mechanisms distinct from those used by HPV18 E7 to antagonize the STING pathway. We identified NLRX1 as a critical intermediary partner to facilitate HPV16 E7-potentiated STING turnover. The depletion of NLRX1 resulted in significantly improved IFN-I-dependent T cell infiltration profiles and tumor control. Overall, we discovered a unique HPV16 viral strategy to thwart host innate immune detection that can be further exploited to restore cancer immunogenicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci129497

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 179

Metadata

Authors
Luo, X., Donnelly, C. R., Gong, W., Heath, B. R., Hao, Y., Donnelly, L. A., Moghbeli, T., Tan, Y. S., Lin, X., Bellile, E., Kansy, B. A., Carey, T. E., Brenner, J. C., Cheng, L., Polverini, P. J., Morgan, M. A., Wen, H., Prince, M. E., Ferris, R. L., Xie, Y., Young, S., Wolf, G. T., Chen, Q., & Lei, Y. L.
Venue
Journal of Clinical Investigation
Published
2020-02-24
Volume
130
Issue
4
Pages
1635-1652
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2998643215
Cited by
179
References
5
FWCI
5.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. https://app.cochat.ai/papers/10.1172/jci129497
The paper
Luo, X., Donnelly, C. R., Gong, W., Heath, B. R., Hao, Y., Donnelly, L. A., Moghbeli, T., Tan, Y. S., Lin, X., Bellile, E., Kansy, B. A., Carey, T. E., Brenner, J. C., Cheng, L., Polverini, P. J., Morgan, M. A., Wen, H., Prince, M. E., Ferris, R. L., . . . Lei, Y. L. (2020). HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. Journal of Clinical Investigation. https://doi.org/10.1172/jci129497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.